Join
Live feed
·
INSIDERFilingvia Quantisnow
Vir Biotechnology Inc. logo

EVP and Chief Medical Officer Eisner Mark was granted 40,000 shares, increasing direct ownership by 53% to 115,000 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
VIR· Vir Biotechnology Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track VIR (Vir Biotechnology Inc.) and more on Quantisnow.